Conduct of Clinical Trials to Facilitate the Development and Approval of Novel Countermeasures (vaccines, devices, drugs) for Use by the Warfighter
Agency: NAVAL MEDICAL LOGISTICS COMMAND
- 12.340 -- Naval Medical Research and Development
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
The goal of this Cooperative Agreement is to engage in a collaborative research and development (R&D) effort to support the research mission of NAMRU-6. The collaborative R&D effort will include conducting clinical trials, and epidemiologic studies in support of clinical trials, so products can be approved/cleared by the U.S. Food and Drug Administration (FDA) for use by the warfighter.
Eligibility
Eligible applicants
Miscellaneous
- Unrestricted
Additional information
Grantor contact information
Description
Grant Specialist Email
Documents
| File name | Description | Last updated |
|---|---|---|
| Question_and_Answer_N62645-PA-20-1_Draft_FINAL.pdf | Question and Answer N62645-PA-20-1 Draft FINAL.pdf | Oct 30, 2019 01:29 PM UTC |
| N62645-PA-20-1-_Application_Instructions.pdf | Application Instructions | Oct 9, 2019 02:41 PM UTC |
| N62645-PA-20-1_-_Program_Announcement.pdf | Program Announcement | Oct 9, 2019 02:41 PM UTC |
Link to additional information
--
Archived: December 8, 2019
Award
$--
Program Funding
1
Expected awards
$--
Award Minimum
$41,822,342
Award Maximum
Funding opportunity number:
N62645-PA-20-01
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
1
Posted date:
October 9, 2019
Archive date:
December 8, 2019
